Skip to main content

Or 34,00 After 66% tax deduction

I make a monthly donation I make an IFI donation
Research, science & health

Decision-making: a new distribution of tasks in our prefrontal cortex?

Published on: 23/06/2022 Reading time: 1 min
cerveau

The team "Motivation, Brain and Behavior", co-directed by Mathias Pessiglione (Inserm) at the Paris Brain Institute, proposes in a study published in the Journal of Neuroscience a new approach to understand how our prefrontal cortex makes decisions.

Decision-making: costs and benefits

Making a decision is based on a fine balance between costs and benefits. In other words, when faced with several options, we must identify the one that will provide the greatest reward with the least effort. When we are faced with this situation, which is almost all the time in our lives, a series of operations take place in our brain to evaluate the different possibilities that are presented to us and choose the best one.

If the role of the prefrontal cortex in the evaluation of effort and reward is well accepted, the functional role of each sub-region is subject to debate, because the results obtained in different studies are contradictory.

Nicolas Clairis First author of the study, currently a post-doctoral fellow at the Ecole Polytechnique Fédéral de Lausanne (EPFL, Switzerland)

Deliberation and confidence in one's own choices

In an attempt to answer this question, Mathias Pessiglione's team at the Paris Brain Institute adopted another approach, in order to clarify the distribution of roles in the prefrontal cortex. To do this, they took into account the metacognitive part of the decision, i.e. the costs and benefits of the deliberation itself (spending time thinking to have more confidence in one's decision). Thus, in a decision such as "Do I continue up to the pass to get the view of the other valley?", one must evaluate not only the option under consideration, i.e., the effort to be made (you have to climb all the way up the scree and that seems difficult) and the reward to come (I've been told that the view is really nice from up there), but also the confidence in the choice under consideration (am I right in wanting to continue?) and the time of deliberation (do I need to think about it more?)

 

The researchers presented 39 participants with several preference tasks that ranged from ratings -- do you like this option a little, a lot, or not at all? - as well as binary decisions -- do you prefer option A or B? Are you willing to put in this much effort for this much reward? These tests were combined with functional imaging (fMRI).

 

A new distribution of tasks in our prefrontal cortex

Their results confirm the role of the ventromedial prefrontal cortex (vmPFC) in assigning a value to the different options presented during a choice. Thus, the activity of this region increases according to the value of the promised reward and decreases according to the cost of the effort required to obtain it. The more dorsal regions of the prefrontal cortex are more associated with the metacognitive variables proposed by the Paris Brain Institute’s team. Confidence in one's own choices is represented in medial prefrontal cortex (mPFC) activity, while deliberation time is reflected active in dorsomedial prefrontal cortex (dmPFC).

 

Here we confirm the value of distinguishing between variables that determine the decision (effort and reward) and those that determine the meta-decision (when to stop one's choice) in understanding the functional architecture of the prefrontal cortex. The advantage of the new conceptual framework is that it can easily be generalized to other types of behavior than choices. For example, to make a judgment, there is also a metacognitive trade-off between confidence and deliberation: one must have confidence in one's judgment, and at the same time one cannot take an infinite amount of time before stopping one's judgment.

Mathias Pessiglione Team leader at the Paris Brain Institute and last author of the study

Sources

https://pubmed.ncbi.nlm.nih.gov/35654606/
Clairis N, Pessiglione M.J Neurosci. 2022 Jun 1

Our news on the subject

À la recherche de marqueurs d’imagerie dans la démence frontotemporale
Searching for Imaging Markers in Frontotemporal Dementia
Could exploring the relationships between different brain networks help us understand frontotemporal dementia (FTD)? This neurodegenerative disease, which progresses at varying rates, is often diagnosed late—when clinical signs are already severe. At...
01.07.2025 Research, science & health
Monocyte – un globule blanc qui se différencie en macrophage. Crédit : Université d’Edinbourg.
Discovery of a Macrophage Anomaly in Multiple Sclerosis
Certain patients with multiple sclerosis (MS) can partially regenerate myelin—the protective sheath that surrounds nerve fibers—which is damaged during the evolution of the disease. In studying how immune cells influence this remyelination...
12.19.2024 Research, science & health
Interneurones. Crédit : UCLA Broad Stem Cell Research Center.
Stimulating specific neurons in the striatum stops compulsive behaviour
What if we could resist compulsions? These irrational behaviours, particularly common in obsessive-compulsive disorder (OCD), are hard to suppress. At Paris Brain Institute, Éric Burguière's team shows that we can anticipate them and block them...
09.10.2024 Research, science & health
Les nerfs moteurs présents dans la moelle épinière se projettent vers la périphérie, où ils entrent en contact avec les muscles, formant des connexions appelées jonctions neuromusculaires. Crédit : James N. Sleigh.
Ultrasound show unexpected effects on motor neuron disease
Over the past fifteen years, neurosurgeons have been perfecting a fascinating technique: using ultrasound to temporarily open the blood-brain barrier to facilitate the action of therapeutic molecules in the central nervous system. At Paris Brain...
09.05.2024 Research, science & health
Un neurone
Rett syndrome: a new gene therapy on the way
Gene therapy could be our best chance of treating Rett syndrome, a neurological disorder that causes severe intellectual and motor impairments. At Paris Brain Institute, Françoise Piguet and her colleagues have looked closely at brain cholesterol...
07.16.2024 Research, science & health
Lésions d’un patient à l’inclusion dans le protocole (M0) disparues après 2 ans de traitement à la Leriglitazone (M24)
The dual effect of leriglitazone in X-linked Adrenoleukodystrophy (X-ALD)
In 2023, the team led by Professor Fanny Mochel (AP-HP, Sorbonne University), a Paris brain Institute researcher, showed that daily dose of leriglitazone slow down the progression of myelopathy in patients with X-linked adrenoleukodystrophy, and...
06.28.2024 Research, science & health
See all our news